Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

33.3%

8 terminated/withdrawn out of 24 trials

Success Rate

60.0%

-26.5% vs industry average

Late-Stage Pipeline

38%

9 trials in Phase 3/4

Results Transparency

17%

2 of 12 completed trials have results

Key Signals

2 with results8 withdrawn

Enrollment Performance

Analytics

Phase 1
11(45.8%)
Phase 3
9(37.5%)
Phase 2
3(12.5%)
N/A
1(4.2%)
24Total
Phase 1(11)
Phase 3(9)
Phase 2(3)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (24)

Showing 20 of 24 trials
NCT06564883Phase 3Not Yet Recruiting

Hydration and Acceptability of the Genital and Skin Mucosa of a Vaginal Moisturizer in Menopausal Women

Role: lead

NCT06085898Not ApplicableUnknown

Stryphnodendron Adstringens Intimate Soap

Role: lead

NCT04880889Phase 3Unknown

BL3000 Compared to Pantogar® in the Treatment of Telogen Effluvium in Women.

Role: lead

NCT04729088Phase 1Withdrawn

Pharmacokinetics Trial of Isosorbide Mononitrate 0.5% Gel for Intra Anal Application in Healthy Subjects

Role: lead

NCT03320486Phase 3Completed

Non-inferiority Trial of Dapaconazole Versus Ketoconazole

Role: lead

NCT03885141Phase 2Unknown

Biolab Zolpidem Orodispersible 1.0 mg, 1.75 mg and 3.5 mg to Treat Maintenance Insomnia Disorder.

Role: lead

NCT03658473Phase 3Completed

Evaluation of Rebamipide and Rabeprazole Effect Associated or Not to Prevent Naproxen-induced Gastric Lesions

Role: collaborator

NCT02817750Phase 1Completed

Pharmacokinetics Study of Zolpidem Hemitartarate Orodispersible Tablet 3.5 mg Formulation

Role: lead

NCT02814058Phase 1Completed

Pharmacokinetics Study of Zolpidem Hemitartarate Orodispersible Tablet 1.75 mg Formulation

Role: lead

NCT02667561Phase 1Withdrawn

Pharmacokinetics, Pharmacodinamic and Safety of Testosterone Gel 1%

Role: lead

NCT02957435Phase 1Withdrawn

Pharmacokinetics Study of Eplerenone Coated Tablets

Role: lead

NCT03443089Phase 1Completed

Comparative Bioavailability of Two Injectable Suspension Formulations of Medroxyprogesterone Acetate+Estradiol Cypionate

Role: collaborator

NCT03441841Phase 1Completed

Pharmacokinetic Study of Nanoencapsulated Gel of Lidocaine, Prilocaine and Combination of Lidocaine and Prilocaine

Role: collaborator

NCT03366246Phase 3Completed

Efficacy of a Topical Anesthetic Containing Lidocaine and Prilocaine in Treatment With CO2 Fractional Laser

Role: collaborator

NCT03359057Phase 3Completed

Trial Evaluating Folic Acid Supplementation by Concomitant Administration of Ethinyl Estradiol + Levonorgestrel

Role: collaborator

NCT03359070Phase 2Completed

Clinical Trial Comparing Dapaconazole Versus Miconazole in Patients With Tinea Cruris

Role: collaborator

NCT02667535Phase 1Withdrawn

PK, PD and Safety Comparative Trial of Isosorbide Mononitrate Gel in Healthy Participants and With Anal Fissure

Role: lead

NCT02632812Phase 1Completed

Gastrointestinal Integrity After Naproxen + Rebamipide Versus Naproxen + Placebo

Role: lead

NCT02606383Phase 3Withdrawn

Non-inferiority Phase III Trial Comparing Dapaconazole Cream 2% With Ketoconazole Cream 2% in Patients With Tinea Pedis

Role: lead

NCT02607657Phase 1Withdrawn

Pharmacokinetics of Eplerenone Tablet

Role: lead